SCHEMBL26435758

SCHEMBL26435758

c1ccc(-c2ccc3oc4cc(-c5nc(-c6ccc(-c7cccc8ccc9ccccc9c78)cc6)nc(-c6cccc7c6oc6ccccc67)n5)ccc4c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
PRKDC P78527 1/20 0.37
ALDH1A1 P00352 4/20 0.35
MAPT P10636 4/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
ABCG2 Q9UNQ0 3/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435022 0.97 ALOX5 (0.40) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26435515 0.94 ALOX5 (0.43) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26435518 0.94 ALOX5 (0.43) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26435686 0.93 ALOX5 (0.43) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26435021 0.93 ALOX5 (0.43) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL26435020 0.93 ALOX5 (0.43) ALOX5PRKDCALDH1A1MAPTKDM4E
SCHEMBL26435692 0.93 ALOX5 (0.44) ALOX5PRKDCALDH1A1MAPTKDM4E
SCHEMBL26435697 0.93 ALOX5 (0.44) ALOX5PRKDCALDH1A1MAPTKDM4E
SCHEMBL25132181 0.92 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL24216243 0.92 ALOX5 (0.45) ALOX5PIM1CSNK2A2CSNK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885PIM1 1568/4885CSNK2A2 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.